Loading organizations...

§ Private Profile · Gwangju, Kwangju-jikhalsi, South Korea
Food technology startup developing cultured meat and seafood alternatives, focused on cell-based tissue formation technology.
CellMEAT is a food technology company based in Gwangju, South Korea, that develops cultured meat and seafood alternatives using proprietary cell-based tissue formation technology. The enterprise focuses on producing alternative protein options, such as lab-grown shrimp and a product called GogiMEAT, utilizing a serum-free cell culture medium to replicate the taste and texture of traditional seafood. Operating with a workforce of 25 employees, the business generates approximately $10.5 million in revenue and is scaling its pilot production capacity to 10 kilograms per day. To support its research and commercialization efforts across Asian and United States markets, the startup has raised $33.6 million in total funding from institutional investors including Strong Ventures, Primer Sazze Partners, NAU IB Capital, and BNK Venture Capital. CellMEAT was officially founded in March 2019 by chief executive officer Giljun Park.
CellMEAT has raised $8.1M across 1 funding round.
CellMEAT has raised $8.1M in total across 1 funding round.
CellMEAT has raised $8.1M across 1 funding round. Most recently, it raised $8.1M Series A in April 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 20, 2022 | $8.1M Series A | — | BNK Venture Investment, NAU IB Capital, Ryukyungpsg Asset Management, Strong Ventures | Announced |
CellMEAT has raised $8.1M in total across 1 funding round.
CellMEAT's investors include BNK Venture Investment, NAU IB Capital, RyukyungPSG Asset Management, Strong Ventures.